Long-term Safety and Tolerability of AFFITOPE AD02

Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD02 Applied During AFFiRiS 002

The purpose of this study is to evaluate the long-term tolerability and -safety of AFFITOPE AD02 applied during AFFiRiS 002

Inclusion Criteria:

• Written informed consent signed and dated by patient and caregiver
• Patients having participated in AFF002 and having received at least 1 vaccination with AFFITOPE AD02
• Availability of a partner/caregiver knowing the patient and being able to accompany the patient to the visits

Exclusion Criteria:

• Patients having received no vaccination with AFFITOPE AD02
• History of questionable compliance to visit schedule, patients not expected to finish the clinical trial